Takeda Pharmaceutical Completes $2.4 Billion Senior Notes Offering
07.25.25
This is only gets display when printing
Simpson Thacher recently represented the underwriters, for which J.P. Morgan Securities LLC and SMBC Nikko Securities America, Inc. acted as representatives, in connection with the offering by Takeda U.S. Financing, Inc. (“Takeda U.S. Financing”) of $1.65 billion of 5.200% Guaranteed Notes due 2035 and $750 million of 5.900% Guaranteed Notes due 2055, fully and unconditionally guaranteed by Takeda Pharmaceutical Company Limited (“Takeda”). The offering was made pursuant to Takeda’s and Takeda U.S. Financing’s shelf registration statement on Form F-3 under the Securities Act.
Takeda is a leading biopharmaceutical company headquartered in Japan with a presence in approximately 80 countries.
The Simpson Thacher team included David Snowden, Weiwei Chen and Anni Cai (Capital Markets) in Tokyo; Michael Mann (Tax) in New York; Vanessa Burrows and Jacob Madden (Healthcare) in Washington D.C. and New York; and Jennie Getsin (FINRA and Blue Sky) in New York.